Delisting risk
Polyrizon (PLRZ)
Develops NASARIX and intranasal hydrogel drug-delivery platforms.
$12.50
Pre-market−0.25 (−1.96%)
At close$12.75(−11.21%)
Something off on this page? Send us feedback.
EPSReportedEstimate
———————Mar '26
Reported———————−$1.96
Estimate————————
Surprise————————
RevenueReportedEstimate
———————Mar '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Jul 2026 | — | — | — |
| Jun 2026 | — | — | — |
| Mar 2026 | — | −$1.96 | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | — | — | — | — | — | — | — |
| Jun 24, 2026 | — | — | — | — | — | — | — |
| Mar 25, 2026 | — | −$1.96 | — | — | — | — | −3.4% |